with no further treatments treatment, the 1996 ten-month follow-up data (n=92) from a high pollen period in oregon, washington and idaho together showed a sinus greater reduction holistic in the active group (n=43) than the placebo group (n=49) treatments on the primary endpoint, defined as a combination of symptom and rescue medication scores.8 patients gave blood serum samples prior to the treatment in 1995 and one year later in 1996. they were immunoassayed for specific ige antibodies using a chemi-luminescent technique. statistician bradley rosebrook ran t-tests comparing average baseline sinus and holistic ige levels to one-year. for the treatments seasonal allergens reported, sinus the holistic active group (n=27) had on average a greater reduction in ige than the placebo group (n=34) for 13 out of 16 allergens. treatments.